# A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain

> **NCT01119924** · PHASE4 · COMPLETED · sponsor: **Nang Kuang Pharmaceutical Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Depression
- Pain

## Interventions

- **DRUG:** Smilon®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01119924
- **Lead sponsor:** Nang Kuang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-08
- **Final completion:** 2010-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119924, "A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01119924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*